NEW YORK, Nov. 30 /PRNewswire-FirstCall/ -- American Oriental Bioengineering Inc. (NYSE: AOB), a leading manufacturer and distributor of plant-based pharmaceutical and nutraceutical products, today announced that the company will present at the ICR XChange Asia institutional investor conference on December 5, 2007 at the Reuters Conference Center in New York City.
Management's presentation will begin at 9:00 a.m. ET at the Reuters Conference Center located at Three Times Square in New York City. At 4:00 pm ET, ICR XChange Asia presenting companies will close the market live on television at the NASDAQ MarketSite.
To register for the ICR XChange Asia please visit http://www.icrxchange.com or contact Wei Jung Yang at 203-682-8200.
About American Oriental Bioengineering Inc.
American Oriental Bioengineering Inc. is a leading, fully integrated, plant based pharmaceutical and plant based nutraceutical company dedicated to improving health through the development, manufacture and commercialization of modernized plant based products in China. For more information, visit http://www.bioaobo.com.
About ICR XChange Asia
The ICR XChange now introduces Asia-based, publicly-traded companies to
key Wall Street constituents: investors, analysts, bankers and capital
markets professionals. Each year, ICR hosts the ICR XChange, known
throughout the institutional investor community as one of the best small
and midcap growth events of the year. The ICR XChange Asia brings ICR's
existing annual conference to the increasingly popular Asian marketplace.
ICR already represents some of the top public companies in the U.S. and
will now bring this expertise to Asia-based companies, so that they too can
enhance shareholder value with effective communications, exposure and the
right Wall Street relationships.
ICR XChange Asia Contact
Bill Zima & Ashley Ammon MacFarlane
Integrated Corporate Relations, Inc.
|SOURCE American Oriental Bioengineering Inc.|
Copyright©2007 PR Newswire.
All rights reserved